We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma

This study has been terminated.
(poor accrual)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00109889
First Posted: May 4, 2005
Last Update Posted: April 24, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2007
  Primary Completion Date: April 2007 (Final data collection date for primary outcome measure)